Search Results
Dr. Cercek on the Need for Treatment Options in KRAS Mutated mCRC
Dr. Cercek on Targeted Strategies in BRAF-Mutant mCRC
Dr. Cercek on the Impact of Tumor Sidedness on Frontline Treatment in mCRC
Dr. Andrea Cercek on CRC Treatment Options | Webinar
Treatment strategies for KRAS-mutant NSCLC with co-mutations
Dr. Channing Der, Ph.D. presents about Targeting KRAS for Cancer Treatment
Sequencing of Therapy in Refractory mCRC
Targeting non-G12C KRAS mutations in NSCLC
Dr. Cercek on the Importance of Molecular Testing in CRC
Mitigating resistance in KRAS-driven cancers
Case 3: KRAS-Mutated Metastatic Colon Cancer
Second-Line Therapy for RAS Wild-Type mCRC
